Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type

RESMED INC   FYE=6 (June)

Annual - Income Statement - Company Specific

Fiscal period2024202320222021202020192018201720162015
Period End Date6/30/20246/30/20236/30/20226/30/20216/30/20206/30/20196/30/20186/30/20176/30/20166/30/2015
Revenues----------2,606.572,340.202,066.741,838.711,678.91
Revenue-Sleep and Respiratory Care products4,101.173,725.023,177.302,823.242,602.38----------
Revenue-Software as a Service584.13497.98400.83373.59354.63----------
Total Revenues4,685.304,222.993,578.133,196.832,957.012,606.572,340.202,066.741,838.711,678.91
Cost of sales----------1,069.99978.03864.99772.22667.52
Voluntary product recall expenses--------------------
Cost of sales-Sleep and Respiratory Care products1,806.851,662.961,365.421,177.311,067.97----------
Cost of sales-Software as a Service190.19173.98148.75135.29121.66----------
Amortization of acquired intangible assets-Sleep and Respiratory Care products5.525.344.114.908.58----------
Amortization of acquired intangible assets-Software as a Service27.4525.0635.5540.2341.02----------
Gross Profit2,655.302,355.662,024.311,839.101,717.791,536.591,362.161,201.751,066.501,011.40
Amortization of acquired intangible assets46.5242.0231.0831.0830.0974.9446.3846.5823.928.67
Research and development307.53287.64253.58225.28201.95180.65155.15144.47118.65114.87
In-process research and development charge (note 20)--------------------
Education, research and settlement charge--------------------
Selling, general and administrative917.14874.00739.37670.39676.69645.01600.37553.97488.06478.63
Restructuring expenses64.239.18--8.67--9.4018.4312.366.91--
Donations to Research Foundations--------------------
Acquisition expenses--(10.95)------(6.12)--(10.08)----
Litigation settlement expenses--------0.60(41.20)--(8.50)----
Total Operating Expenses1,335.411,223.791,024.03935.42908.13957.32820.33775.95637.55602.16
Operating Income (Loss)1,319.891,131.871,000.29903.68809.66579.26541.83425.80428.95409.24
Interest expense45.7147.3822.3123.9940.3836.1628.3628.2411.215.78
Loss attributable to equity method investments(1.85)(7.27)(8.49)(11.21)(25.06)(15.83)--------
Gain (loss) on equity investments (note 5)(4.05)9.92(12.20)--------------
Interest income (expense), net------0.361.022.3016.3817.0916.8626.21
Other, net(3.49)(5.71)3.2014.82(12.16)(10.73)(8.54)4.104.966.25
Gain (loss) on extinguishment of debt--------------------
Government grants--------------------
Other: License fees--------------------
Other: Gain/(loss) on foreign currency hedging position--------------------
Other: Gain/(loss) on foreign currency transactions--------------------
Other: Other--------------------
Other: Realized gain on sale of marketable securities--------------------
Other: Impairment of cost method investment--------------------
Other: Gain on sale of real property--------------------
Other: Gain on sale of plant and equipment--------------------
Other: Gain on sale of business assets and contracts--------------------
Gain on insurance recoveries (1)--20.23----------------
Total other income (expenses), net(55.10)(30.21)----------------
Pre-Tax Income - U.S181.11128.59(85.92)71.8760.55(34.47)42.63(4.99)----
Non-U.S1,083.69973.081,046.40811.80672.54553.32478.69423.73----
Income before Income taxes1,264.801,101.66960.48883.66733.09518.85521.31418.74439.57435.92
Current: Federal57.1036.634.38(115.11)9.7928.66128.9716.4724.3328,429.00
Current: State17.2514.1410.709.046.907.600.95(1.16)5.81695.00
Deferred: Federal(22.92)(21.72)(12.61)(22.79)(13.00)(30.46)9.4911.395.64(4,269.00)
Deferred: State(4.63)(2.39)(2.77)(4.21)(3.34)(5.41)(0.35)2.71(1.64)(180.00)
Current- Non-U.S219.37198.77177.79531.81124.60127.5468.8665.6158.0250,892.00
Deferred- Non-U.S(22.33)(21.32)3.5710.41(13.54)(13.67)(2.19)(18.55)(4.99)7,463.00
Income taxes243.85204.11181.05409.16111.41114.26205.7276.4687.1683.03
Net Income (Loss) Available to Common Shareholders1,020.95897.56779.44474.51621.67404.59315.59342.28352.41352.89
Continuing Operations- (Basic)--------------------
Basic Earnings Per Share6.946.125.343.274.312.832.212.422.512.51
Continuing Operations- (Diluted)--------------------
Diluted Earnings Per Share6.926.095.303.244.272.802.192.402.492.47
Weighted Average Shares Outstanding (Basic)147.02146.77146.07145.31144.34143.11142.76141.36140.24140.47
Weighted Average Shares Outstanding (Diluted)147.55147.46147.04146.45145.65144.48143.99142.45141.67142.69